Michael F. BRADLEY

Person

Covington, WA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Salt and crystalline forms thereof of a drug
- Patent number 10,329,276
- Issue date Jun 25, 2019
- AbbVie Inc.
- Geoff G. Z. Zhang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Salt and crystalline forms thereof of a drug
- Patent number 9,873,681
- Issue date Jan 23, 2018
- AbbVie Inc.
- Geoff G. Z. Zhang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Salt and crystalline forms thereof of a drug
- Patent number 9,539,250
- Issue date Jan 10, 2017
- AbbVie Inc.
- Geoff G. Z. Zhang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Salt and crystalline forms thereof of a drug
- Patent number 8,969,569
- Issue date Mar 3, 2015
- AbbVie Inc.
- Geoff G. Z. Zhang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Salt and crystalline forms thereof of a drug
- Patent number 8,648,093
- Issue date Feb 11, 2014
- AbbVie Inc.
- Geoff G. Z. Zhang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Salt and crystalline forms thereof of a drug
- Patent number 8,273,892
- Issue date Sep 25, 2012
- Abbott Laboratories
- Geoff G. Z. Zhang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Salt and crystalline forms thereof of a drug
- Patent number 8,252,813
- Issue date Aug 28, 2012
- Abbott Laboratories
- Geoff G. Z. Zhang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Salt and crystalline forms thereof of a drug
- Patent number 7,728,143
- Issue date Jun 1, 2010
- Abbott Laboratories
- Geoff G. Z. Zhang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Ureas having antiangiogenic activity
- Patent number 7,592,466
- Issue date Sep 22, 2009
- Abbott Laboratories
- Fortuna Haviv
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tetra-, penta-, hexa- and heptapeptides having antiangiogenic acti...
- Patent number 7,169,888
- Issue date Jan 30, 2007
- Abbott Laboratories
- Fortuna Haviv
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Hexa-, hepta-, and octapeptides having antiangiogenic activity
- Patent number 7,122,625
- Issue date Oct 17, 2006
- Abbott Laboratories
- Fortuna Haviv
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Hepta-, Octa-and nonapeptides having antiangiogenic activity
- Patent number 7,067,490
- Issue date Jun 27, 2006
- Abbott Laboratories
- Fortuna Haviv
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
TRI-, TETRA-, and penta-peptides having antiangiogenic activity
- Patent number 7,037,897
- Issue date May 2, 2006
- Abbott Laboratories
- Fortuna Haviv
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Di-, tri-, and tetra-peptides having antiangiogenic activity
- Patent number 7,001,984
- Issue date Feb 21, 2006
- Abbott Laboratories
- Fortuna Haviv
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
N-alkylated peptides having antiangiogenic activity
- Patent number 6,777,535
- Issue date Aug 17, 2004
- Abbott Laboratories
- Fortuna Haviv
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Peptide antiangiogenic drugs
- Patent number 6,774,211
- Issue date Aug 10, 2004
- Abbott Laboratories
- Jack Henkin
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Peptides having antiangiogenic activity
- Patent number 6,753,408
- Issue date Jun 22, 2004
- Fortuna Haviv
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Peptide antiangiogenic drugs
- Patent number 6,716,963
- Issue date Apr 6, 2004
- Abbott Laboratories
- Jack Henkin
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
SALT AND CRYSTALLINE FORMS THEREOF OF A DRUG
- Publication number 20180105510
- Publication date Apr 19, 2018
- ABBVIE INC.
- Geoff G.Z. ZHANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SALT AND CRYSTALLINE FORMS THEREOF OF A DRUG
- Publication number 20170073329
- Publication date Mar 16, 2017
- ABBVIE INC.
- Geoff G.Z. ZHANG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Salt and Crystalline Forms Thereof of a Drug
- Publication number 20150196547
- Publication date Jul 16, 2015
- ABBVIE INC.
- Geoff G.Z. ZHANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Salt and Crystalline Forms Thereof of a Drug
- Publication number 20140155380
- Publication date Jun 5, 2014
- ABBVIE INC.
- Geoff G.Z. ZHANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Salt and Crystalline Forms Thereof of a Drug
- Publication number 20130060040
- Publication date Mar 7, 2013
- Abbott Laboratories
- Geoff G.Z. Zhang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SALT AND CRYSTALLINE FORMS THEREOF OF A DRUG
- Publication number 20100286397
- Publication date Nov 11, 2010
- Geoff G.Z. Zhang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SALT AND CRYSTALLINE FORMS THEREOF OF A DRUG
- Publication number 20100261703
- Publication date Oct 14, 2010
- Abbott Laboratories
- Geoff G.Z. Zhang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TETRA-, PENTA-, HEXA- AND HEPTAPEPTIDES HAVING ANTIANGIOGENIC ACTIVITY
- Publication number 20080071062
- Publication date Mar 20, 2008
- Fortuna Haviv
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Hexa-, Hepta-, and Octapeptides Having Antiangiogenic Activity
- Publication number 20070167376
- Publication date Jul 19, 2007
- Fortuna Haviv
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD OF INHIBITING ANGIOGENESIS
- Publication number 20070043089
- Publication date Feb 22, 2007
- Fortuna Haviv
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Salt and crystalline forms thereof of a drug
- Publication number 20070043019
- Publication date Feb 22, 2007
- Geoff G.Z. Zhang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD OF INHIBITING ANGIOGENESIS
- Publication number 20070032527
- Publication date Feb 8, 2007
- Fortuna Haviv
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Hepta-, octa-and nonapeptides having antiangiogenic activity
- Publication number 20060194737
- Publication date Aug 31, 2006
- Fortuna Haviv
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Ureas having antiangiogenic activity
- Publication number 20060160806
- Publication date Jul 20, 2006
- Fortuna Haviv
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Substituted pyridines having antiangiogenic activity
- Publication number 20060030557
- Publication date Feb 9, 2006
- Fortuna Haviv
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Di-, tri-, and tetra-peptides having antiangiogenic activity
- Publication number 20050215484
- Publication date Sep 29, 2005
- Fortuna Haviv
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Peptide antiangiogenic drugs
- Publication number 20050124548
- Publication date Jun 9, 2005
- Jack Henkin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Method of inhibiting angiogenesis
- Publication number 20040116479
- Publication date Jun 17, 2004
- Fortuna Haviv
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Method of inhibiting angiogenesis
- Publication number 20040067985
- Publication date Apr 8, 2004
- Fortuna Haviv
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Substituted pyridines having antiangiogenic activity
- Publication number 20040014744
- Publication date Jan 22, 2004
- Fortuna Haviv
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Octa- and nonapeptides having antiangiogenic activity
- Publication number 20030125259
- Publication date Jul 3, 2003
- Fortuna Haviv
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Tetra-and pentapeptides having antiangiogenic activity
- Publication number 20030125260
- Publication date Jul 3, 2003
- Fortuna Haviv
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Penta- and hexapeptides having antiangiogenic activity
- Publication number 20030125261
- Publication date Jul 3, 2003
- Fortuna Haviv
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HEXA- and heptapeptides having antiangiogenic activity
- Publication number 20030119745
- Publication date Jun 26, 2003
- Fortuna Haviv
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Hepta-and octapeptides having antiangiogenic activity
- Publication number 20030119746
- Publication date Jun 26, 2003
- Fortuna Haviv
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Hexa-, hepta-, and octapeptides having antiangiogenic activity
- Publication number 20030114386
- Publication date Jun 19, 2003
- Fortuna Haviv
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HEPTA-, OCTA-and nonapeptides having antiangiogenic activity
- Publication number 20030109455
- Publication date Jun 12, 2003
- Fortuna Haviv
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRI-, TETRA-, and penta-peptides having antiangiogenic activity
- Publication number 20030109456
- Publication date Jun 12, 2003
- Fortuna Haviv
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
DI-, TRI-, and tetra-peptides having antiangiogenic activity
- Publication number 20030109458
- Publication date Jun 12, 2003
- Fortuna Haviv
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Tetra-, penta-, hexa- and heptapeptides having antiangiogenic activity
- Publication number 20030105023
- Publication date Jun 5, 2003
- Fortuna Haviv
- C07 - ORGANIC CHEMISTRY

Michael F. BRADLEY

Person

Patents Grantslast 30 patents

Salt and crystalline forms thereof of a drug

Salt and crystalline forms thereof of a drug

Salt and crystalline forms thereof of a drug

Salt and crystalline forms thereof of a drug

Salt and crystalline forms thereof of a drug

Salt and crystalline forms thereof of a drug

Salt and crystalline forms thereof of a drug

Salt and crystalline forms thereof of a drug

Ureas having antiangiogenic activity

Tetra-, penta-, hexa- and heptapeptides having antiangiogenic acti...

Hexa-, hepta-, and octapeptides having antiangiogenic activity

Hepta-, Octa-and nonapeptides having antiangiogenic activity

TRI-, TETRA-, and penta-peptides having antiangiogenic activity

Di-, tri-, and tetra-peptides having antiangiogenic activity

N-alkylated peptides having antiangiogenic activity

Peptide antiangiogenic drugs

Peptides having antiangiogenic activity

Peptide antiangiogenic drugs

Patents Applicationslast 30 patents

SALT AND CRYSTALLINE FORMS THEREOF OF A DRUG

SALT AND CRYSTALLINE FORMS THEREOF OF A DRUG

Salt and Crystalline Forms Thereof of a Drug

Salt and Crystalline Forms Thereof of a Drug

Salt and Crystalline Forms Thereof of a Drug

SALT AND CRYSTALLINE FORMS THEREOF OF A DRUG

SALT AND CRYSTALLINE FORMS THEREOF OF A DRUG

TETRA-, PENTA-, HEXA- AND HEPTAPEPTIDES HAVING ANTIANGIOGENIC ACTIVITY

Hexa-, Hepta-, and Octapeptides Having Antiangiogenic Activity

METHOD OF INHIBITING ANGIOGENESIS

Salt and crystalline forms thereof of a drug

METHOD OF INHIBITING ANGIOGENESIS

Hepta-, octa-and nonapeptides having antiangiogenic activity

Ureas having antiangiogenic activity

Substituted pyridines having antiangiogenic activity

Di-, tri-, and tetra-peptides having antiangiogenic activity

Peptide antiangiogenic drugs

Method of inhibiting angiogenesis

Method of inhibiting angiogenesis

Substituted pyridines having antiangiogenic activity

Octa- and nonapeptides having antiangiogenic activity

Tetra-and pentapeptides having antiangiogenic activity

Penta- and hexapeptides having antiangiogenic activity

HEXA- and heptapeptides having antiangiogenic activity

Hepta-and octapeptides having antiangiogenic activity

Hexa-, hepta-, and octapeptides having antiangiogenic activity

HEPTA-, OCTA-and nonapeptides having antiangiogenic activity

TRI-, TETRA-, and penta-peptides having antiangiogenic activity

DI-, TRI-, and tetra-peptides having antiangiogenic activity

Tetra-, penta-, hexa- and heptapeptides having antiangiogenic activity